73
29
Growth Score 73 in past quarter
-10 pts
Heat Score 29 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
528855
QED Bioscience is a company which develops novel monoclonal and polyclonal antibody products
- Eileen Skaletsky: President and CEO
About the Company
QED Bioscience has been designing and manufacturing antibodies for over 20 years, and throughout their history, their goals have remained unchanged: provide the best antibody products and services on the market and support their clients with the expertise and assistance they should expect from a full-spectrum antibody company like QED. QED
Bioscience develops novel monoclonal and polyclonal antibody products for our academic, biotechnology, diagnostic and pharmaceutical research clients.
Women Founded